Anergy and acquired immune deficiency syndrome

Medical Hypotheses

Volumn 56, Issue 2, 2001, Pages 250-255

  Hegde, H R ^a   Woodman, R C ^a   Robbins, S M ^a  

^a Peter Lougheed Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER RISK; CLONAL ANERGY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; MALNUTRITION; PRIORITY JOURNAL; RECEPTOR BINDING;

HUMAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0035093680     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1190     Document Type: Article

References (37)

1. New concepts in AIDS pathogenesis
2. Unified hypothesis for three cardinal features of HIV immunology
3. Anergy, AIDS and tuberculosis
4. Mechanisms of Anergy in AIDS and Malnutrition
5. The molecules of the immune system
6. Update on the immunodeficiency disease
7. CD28-mediated signalling co-stimulates routine T-cells and prevents induction of anergy in T-cell clones
8. Purified Protein Derivative (PPD)-tuberculin anergy and HIV Infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis
9. The prognostic utility of delayed type hypersensitivity skin testing in the evaluation of HIV-infected patients
10. How does HIV cause AIDS?
11. Interleukin-12: A bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency
12. Low concentration of acid-soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients
13. HIV-induced cysteine deficiency and T-cell dysfunction - A rationale for treatment with N-acetyl cysteine
14. Transforming growth factor β and non-cytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection
15. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy
16. HIV-mediated defects in immune regulation
17. lck
18. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism
19. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines
20. Ick activation and TCR desensitization independent of TCR tyrosine phosphorylation
21. T-cell dysfunction in HIV infection: Anergy due to defective antigen-presenting cell function?
22. Programmed cell death induced by HIV Type 1 antigen stimulation is associated with a decrease in cytotoxic T-lymphocyte activity in advanced HIV Type 1 infection
23. + T-cells in HIV infection add to the prognostic value of low CD4 T-Cell levels: Results of six years of follow-up
24. Two types of murine helper T-cell clone. Definition according to profiles of lymphokine activities and secreted proteins
25. Interleukin-12 and its role in the generation of Th-1 cells
26. Evidence for a shift from a Type 1 lymphocyte pattern with HIV disease progression
27. H 2 switch is a critical step in the etiology of HIV infection
28. Immunoglobulin VH3 gene products: Natural ligands for HIV gp120
29. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
30. IL- 12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation
31. Apoptosis by Death Factor
32. Cell autonomous Fas (CD95)/Fas-ligand interaction mediates activation induced apoptosis in T-cell hybridomas
33. The relationship between AIDS and immunologic tolerance
34. Sensitization of T cells to CD95 - Mediated apoptosis by HIV-1 Tat and gp120
35. CD95-induced apoptosis contributes to loss of primed/memory but not resting/näive T-cells in children infected with human immune deficiency virus Type-1
36. Anergy skin testing and preventive therapy for HIV-infected persons: Revised recommendations